Auxein launched a range of Innovative advanced Orthopedic and Arthroscopy Product at MEDICA 2024

November 19, 2024 03:30 PM AEDT | By EIN Presswire
 Auxein launched a range of Innovative advanced Orthopedic and Arthroscopy Product at MEDICA 2024
Image source: EIN Presswire

A range of Innovative advanced Orthopedic and Arthoscopy Products launched by Auxein at MEDICA 2024

DELHI, INDIA, November 19, 2024 /EINPresswire.com/ -- • 5,800 exhibiting companies from 72 nations presented their expertise to some 80,000 trade visitors (from 165 countries)
• Auxein is Asia’s First Orthopaedic Implant Manufacturer to Achieve EU-MDR Certification for its Trauma Plating, Screws, and Nailing Systems

Auxein, a global leader in orthopaedic Products, is overwhelmed to announce the tremendous success of its participation in MEDICA 2024, which took place from November 11-14 in Düsseldorf, Germany. With over 5,800 exhibiting companies from 72 nations presented their expertise to some 80,000 trade visitors (from 165 countries), MEDICA proved once again to be one of the world’s largest and most prestigious medical technology trade fairs, and Auxein’s presence was a key highlight.

Auxein's booth was buzzing with activity as the company showcased its latest innovations in orthopaedic Products. The company received an overwhelming response from thousands of industry professionals, healthcare providers, medical distributors, and experts from around the world, all eager to explore Auxein’s diverse range of products designed to improve patient outcomes and streamline surgical procedures.

A range of Innovative advanced Orthopedic and Arthoscopy Products launched by Auxein at MEDICA 2024 included variety of AV-Wiselock Plates, Osteochondral Transfer System, Reusable Suture Passer, Ligament Augmentation Repair Instrument Set, Auxilock Silicon Cannula, Auxilock Rigid Threaded Cannula, Reusable Suture Passer, Knee Escorpian Suture Passer, Bioabsorbable Interference screw, Bioabsorbable Anchors, GFS Ultimate Button with Brace/Tape System, etc.

Mr. Rahul Luthra, Vice President of Global Sales & Marketing at Auxein, shared his excitement:
“We are absolutely delighted with the incredible turnout at MEDICA 2024. The overwhelming interest in our products is a testament to the global recognition of Auxein’s commitment to advancing orthopaedic Products. Our engagement with professionals from all over the world reaffirmed our mission to provide innovative Products that address the evolving needs of patients and healthcare providers alike."

In addition to its successful showcase at MEDICA 2024, Auxein proudly highlighted several major milestones that further solidified its leadership in the global orthopaedic market. Auxein strengthened its leadership in global orthopaedic Products by becoming Asia’s first orthopaedic implant manufacturing organization to achieve EU-MDR Certification for trauma plating, screws, and nailing systems. This certification ensures that Auxein's trauma orthopaedic Products meet the stringent safety and quality requirements for the European market, reinforcing the company’s leadership in delivering world-class medical technology.

Auxein also unveiled a new range of advanced and innovative orthopaedic Products at MEDICA 2024, designed to address the growing demand for minimally invasive procedures and faster recovery times. The innovative range included state-of-the-art customized implants, which offer improved patient outcomes through enhanced compatibility and reduced post-operative complications.

Recently, Auxein made its debut at IASCON 2024, where the company showcased its groundbreaking research on bioabsorbable screws and engaged with the arthroscopy community. Bioabsorbable implants are set to revolutionize orthopaedic surgery. Made from biocompatible materials, these innovative implants dissolve gradually in the body, providing temporary support that aids in natural healing and tissue regeneration. Unlike traditional metallic implants, bioabsorbable options minimize complications, reducing the need for invasive removal surgeries and decreasing the risk of infections and metal sensitivity.

These recent accomplishments, alongside Auxein's strong product portfolio, earned the company widespread recognition in the orthopaedic community, and its presence at MEDICA 2024 further reinforced its position as a leading innovator in the field.

About Auxein Medical: Auxein is dedicated to advancing medical technology through innovative Orthopedic and Arthroscopy Products, committed to improving patient outcomes worldwide. We deliver excellence through cutting-edge research, superior manufacturing, and a deep understanding of healthcare needs.

250+ CNC, VMC, and Sliding Head Machines | 500+ Employees | 20+ Million Patients Cared For | 200+ FDA-Approved Products | 3000+ Products | Asia’s First to Achieve EU-MDR Certification

For more information about Auxein please visit: https://www.auxein.com/

For more information about DAIS Academy, please visit: https://www.dais.academy/

Media Contact: Ms. Neeti Mathur, Head- Corporate Communication & Public Relations | +91 7419770140 | +91 9711306375 | [email protected]

Neeti Mathur
Auxein Medical
+91 97113 06375
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.